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Behavioral flexibility is subserved by the prefrontal cortex and the basal ganglia. Orbitofrontal cortex (OFC) and dorsomedial striatum 
(DMS) form a functional frontocorticostriatal circuit crucial for the mediation of flexibility during reversal learning via dopamine (DA) 
neurotransmission. The regulatory control in maintaining DA homeostasis and function is provided by the dopamine transporter (DAT), 
which therefore likely plays a significant role in controlling the influence of DA on cognitive processes. Here we used a gene knockout 
mouse model to investigate the role of DAT in the performance on the Attentional Set‑Shifting Task (ASST) stages dependent upon the 
OFC and the DMS. Additionally, behavior of mice after repeated administration of selective DAT inhibitor, GBR 12909, was examined. 
The animals were treated with the inhibitor to elicit a  compensatory DAT up‑regulation following withdrawal. Learning was slower 
and the number of errors during reversal learning and intra‑dimensional shift stages was higher in DAT+/− mutant mice than in WT 
mice. GBR 12909‑treated mice had deficits in reversal stages of the ASST. Neuronal activation in the OFC and DMS during the ASST was 
examined with early growth response proteins 1 and 2 (egr‑1, egr‑2) immunohistochemistry. Density of egr‑2 labeled cells in the OFC 
was lower in mutant mice than in wild‑types during reversal learning and the expression of the egr‑1 was lower in mutant mice in the 
OFC and DMS during reversal and intra‑dimensional shift stages. Mice with decreased DAT levels displayed behavioral difficulties that 
were accompanied by a lower task‑induced activation of neurons in brain regions involved in the reversal learning. Altogether, these 
data indicate the role of the DAT in the behavioral flexibility.
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INTRODUCTION 
It is well known that learning and behavioral 
flexibility are subserved by the prefrontal cortex 
(PFC). Distinct regions of PFC mediate different forms 
of flexibility. The results of several studies point to 
a crucial role of the medial prefrontal cortex (mPFC) in 
shifting between strategies or attentional sets, while 
the orbitofrontal cortex (OFC) has been implicated in 
reversal learning (Dias et al. 1996, Ragozzino et al. 1999, 
Birrell and Brown 2000, McAlonan and Brown 2003, 
Boulougouris et al. 2007). However, flexible behavior is 
not solely supported by the PFC, but rather by a complex 
neural network, which includes the striatum (Kolb 1977, 
Ragozzino 2007, Clarke et al. 2008). Inactivation or 
lesion of the dorsomedial striatum (DMS) in rats impairs 
reversal learning (Ragozzino et al. 2002a, 2002b, Clarke 
et al. 2008, Castañe et al. 2010, Tait et al. 2017). 
PFC is very sensitive to the imbalance in its 
neurotransmitters and even small changes in 
catecholamine modulation of PFC cells can have profound 
effects on its ability to control executive functions. 
The dopamine (DA) system is implicated in executive 
control of cognitive processes (Robbins and Roberts 2007, 
Ranganath and Jacob 2015), in flexible behavior (Haluk 
and Floresco 2009) and in synaptic plasticity in brain 
regions supporting reversal learning performance, i.e. 
PFC and striatum (Reynolds and Wickens 2002, Cagniard et 
al. 2006a, 2006b, Calabresi et al. 2007). The most important 
regulatory control of temporal and spatial activity of 
released DA is provided by the dopamine transporter 
(DAT) (Cook et al. 1995, Lohr et al. 2017). Alternations 
in dopaminergic modulation in frontocorticostriatal 
circuits are associated with schizophrenia (e.g. Ratajczak 
et al. 2015) and attention deficit hyperactivity disorder 
(ADHD) symptoms (Biederman and Faraone 2005, Arnsten 
2006) and changes in DAT level in the striatum have 
been found in patients with ADHD (Krause 2008). The 
most effective treatments for ADHD are medications 
that enhance dopamine transmission by inhibiting 
DAT action (e.g. Mazei‑Robinson and Blakely 2006). In 
spontaneously hypertensive rats (SHR), an animal model 
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of ADHD, altered dopamine activity in the OFC leads to the 
deficits in reversal learning (Cheng et al. 2013). Based on 
that result it was postulated that orbitofrontal dopamine 
system might be an essential part in the neural pathology 
responsible for the dysfunction of inhibitory control 
observed in ADHD (Cheng et al. 2013).
The executive functions related to attention, 
inhibitory control and behavioral flexibility can be 
tested with the intra‑dimensional/extra‑dimensional 
Attentional Set‑Shifting Task (ASST), which is available 
for humans (Owen et al. 1993), monkeys (Dias et al. 
1997), rats (Birrell and Brown 2000) and mice (Bissonette 
et al. 2008, Young et al. 2010). That task comprises of 
a series of perceptual discriminations that require an 
animal to form an attentional set, to shift an attentional 
set within and between dimensions and also to alter 
behavior under reversal conditions (Birrell and Brown 
2000). The behavioral deficits observed in DAT‑KO mice 
are reminiscent of the deficiencies in executive functions 
noticeable in ADHD and it was postulated that the study 
of DAT‑KO mice can contribute to better understanding 
of the molecular basis of this and other dopamine‑related 
neuropsychiatric disorders. However, it is unlikely that 
complete absence of DAT functions occurs in ADHD 
patients, and therefore it might be more appropriate to 
study DAT heterozygous mice, which are less extreme case 
of a DAT dysfunction (Gainetdinov and Caron 2003). DAT 
heterozygotes are characterized by heightened levels of 
DA synthesis and turnover, with increased extracellular 
DA levels in the striatum and nucleus accumbens and 
reduced tissue levels of DA (Giros et al. 1996, Jones et al. 
1998, Gainetdinov and Caron 2003). We have described 
behavioral deficits of DAT heterozygous mice in the intra‑ 
and extra‑dimensional shifts of attention, accompanied 
by deficiencies in the task‑induced activation of neurons 
in mPFC and posterior parietal cortex (PPC) regions 
(Cybulska‑Klosowicz et al. submitted). The purpose of the 
current study was to examine whether normal expression 
of DAT is also required for optimal neuronal activation in 
brain regions supporting reversal learning performance, 
i.e. OFC and striatum, during training in the ASST. The 
performance of WT and DAT heterozygous mice in the 
ASST was analyzed and the task‑induced expression of 
the early growth response proteins 1 (egr‑1, Zif‑268) 
and 2 (egr‑2, Krox‑20) in the OFC and DMS during ASST 
stages was compared. Induction of the egr‑1 depends on 
neuronal activity and is thought to be involved in neuronal 
plasticity (Cole et al. 1989), learning and memory (e.g. 
Hall et al. 2001, Bozon et al. 2003), while the level of egr‑2 
expression in the prefrontal cortex (OFC and mPFC) was 
found to correlate with the magnitude of cognitive control 
involved in the task performance (DeSteno and Schmauss 
2008). Beside the DAT mutant mice, we also examined the 
mice withdrawn from the treatment with the potent and 
selective DAT inhibitor, GBR 12909 (Heikkila and Manzino 
1984). It has been postulated that withdrawal from GBR 
12909 induces a rebound DAT over‑expression and it 
has been demonstrated that it results in mild increases 
in locomotor activity and deficits in discrimination 
abilities in the novel object discrimination task (Hewitt 
et al. 2005, 2009). 
MATERIALS AND METHODS
Animals
DAT+/− (n=39) and wild‑type (n=39) littermate 
female mice 10–15 weeks of age were used in this study. 
Homozygous DAT‑KO, heterozygous DAT+/−, and WT mice 
were obtained by homologous recombination as previously 
described (Giros et al. 1996), and the two B6‑DAT and 
D2‑DAT congenic strains were maintained by consistently 
backcrossing for more than 12 generations onto the B6 
and D2 inbred strains as previously described (Morice et 
al. 2007). The couples of founders for the cohort used in 
this study were obtained from Prof. B. Giros. The mice were 
bred in the Animal Facility, Faculty of Biology, University 
of Warsaw and weaned at 4 weeks. Then they were housed 
under standard conditions, on a 12 h light/dark cycle in 
the Animal House, Nencki Institute. The genotypes of the 
animals were determined by PCR analysis with the use of 
the primers DAT‑1 (CCCGTC TACCCATGAG‑TAAAA), DAT‑2 
(C TCCACC TTCC TAGCAC TAAC), and NEO2 (TGACCGC 
TTCC TCGTGC) (Carboni et al. 2001). 
Experiment with DAT inhibitor, GBR 12909, was 
performed on 15 C57BL/6J female mice ~6 weeks of age. 
The animals were kept in a temperature‑controlled room 
with a natural light/dark (12‑h:12‑h) cycle.
All work was conducted in accordance with the 
European Community Council Directive (2010/63/EU) 
and was approved by the Local Ethics Committee No. 1 in 
Warsaw.
GBR 12909 administration
GBR 12909 dihydrochloride (1‑[2‑[bis(4‑fluorophenyl)
m e t h ox y ] e t h y l ] ‑ 4 ‑ ( 3 ‑ p h e n y l p ro p y l ) p i p e r a z i n e 
dihydrochloride) (Tocris, Bristol, UK) was administered 
(20 mg/kg) by intraperitoneal injection. Animals were 
treated twice a day (between the hours of 07.00–8.00 h and 
16.00–17.00 h) for 4 consecutive days. Two groups of mice 
received either GBR 12909 (n=7) or vehicle (sterile water) 
(n=8) ascribed in a pseudorandom manner.
The first discrimination stage of the ASST (simple 
discrimination) was performed on these mice 10 days 
following withdrawal from the drug treatment regime.
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Attentional set‑shifting task (ASST)
The ASST was developed as a measure of attention 
and behavioral flexibility in rats (Birrell and Brown 
2000). ASST is a rodent version of the intra‑dimensional/
extra‑dimensional component of the Cambridge 
Neuropsychological Test Automated Battery (CANTAB) 
which is used to identify cognitive dysfunction in humans 
and non‑human primates (Nagahara et al. 2010, Rock et 
al. 2014). In the ASST task animals learn to discriminate 
between two perceptual dimensions: odor and texture. 
Test apparatus
The test apparatus was a wooden cage (30×38×21 cm). 
Additional panel divided half of the length of the cage 
into two “choice” sections in which the digging bowls 
were placed and a removable divider separated these two 
“choice” sections from the “start” section. The digging 
bowls (glass pots; interior diameter 4.5 cm, depth 5 cm) 
were filled to the inner rim with digging media of different 
textures (gravel, wool, plastic pellets, straws, pleated paper 
strips, coarse sand). The digging media were scented with 
various flavoring essences (lemon, almond, orange, vanilla, 
arrack, rum; Dr. Oetker®, Poland) (see Table I for examples). 
During testing the bowls were baited with small pieces of 
sweetened dry breakfast cereal (DottyChrups, Otmuchow, 
Poland), which were placed on the bottom of the glass pot 
and buried under the digging media. Only one of the bowls 
was baited and mice were required to learn to pay attention 
and respond to the relevant dimension (e.g., odor) and 
ignore an irrelevant dimension (e.g., digging medium).
Handling and habituation period
Before testing mice were handled for 5 days. During that 
time they were habituated with the bowl filled with the 
reinforcer in their home cage for 24h and then acclimated 
with the reinforcer presented in the digging bowls filled 
with the media and placed in the testing apparatus for 
10 min per day for 2 days, or as many days as they needed 
to be habituated and to consume the reinforcer. The 
non‑discriminable digging media were used and were not 
scented during that period and the reinforcer was placed 
in both digging bowls. A piece of the food reinforcer was 
placed on top of the digging media during the first day of 
habituation and covered with a thin layer of the medium on 
the second day. Mice were allowed to consume the retrived 
food revard before being returned to the home cage. When 
mice were habituated enough to consumed the reinforcer, 
the same non‑discriminable media were scented, each 
of the bowl with different odor, and only one was baited 
with the reinforcer. Mice were trained to a criterion of six 
consecutive correct trials in that pre‑test. After habituation 
period mice were moved to the first stage of the ASST. 
Behavioral paradigm
The animals had no access to food for approximately 
12 hours before testing, while water was freely available 
in the home cage all the time. The order of the training 
discriminations (odor and medium), the reinforced odor 
and medium and their left or right position in the test 
apparatus were determined pseudorandomly. Mice were 
allowed 3 minutes of exploration; if the response (digging) 
did not occur in that time, the trial was terminated and an 
error of omission was recorded. An error of commission 
was recorded if the mouse dug in the unbaited bowl and the 
trial was terminated. Digging was defined as active digging 
with both front paws or active foraging with the snout in 
the digging medium (Birrell and Brown 2000). Mice were 
trained to a criterion of six consecutive correct trials in all 
stages of the ASST. The number of trials to criterion was 
counted for each test stage.
Six discrimination phases (Birrell and Brown 2000, 
Glickstein et al. 2005) comprised the ASST and were 
performed in the following order: simple discrimination 
(SD), compound discrimination (CD), reversal learning 
(Rev), intra‑dimensional shift (IDS), extra‑dimensional 
shift (EDS) and reversal of the EDS (EDS‑Rev). An example 
of the entire task is shown in Table II. In the SD the bowls 
differed along one of two dimensions and mice learned 
to discriminate of either two different odors or two 
digging media. There were three “exploratory” trials 
at the beginning of that stage, where the mice, after 
an error, were allowed to retrieve the reinforcer from 
the correct bowl. Responses of an animal during these 
“exploratory” trials were not included into analyses. The 
Table I. Exemplar pairs of stimuli used in the ASST
dimension exemplar pairs
digging medium
gravel wool straws
coarse sand pleated paper strips plastic pellets
odor
lemon almond orange
vanilla arrack rum
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following CD stage had the same correct (reinforced) and 
incorrect (non‑reinforced) stimulus properties as the SD, 
but a new irrelevant dimension was introduced. For the 
Rev stage, the relevant dimension and the stimuli were 
unchanged, however the previously correct stimulus was 
now non‑reinforced. The next test phase required a shift 
of attention within the dimension (intra‑dimensional 
shift, IDS). In this stage both correct and incorrect 
stimuli changed, but the relevant dimension (either 
odor or medium) remained the same. In the next stage 
shifting of attention between dimensions was required 
(extra‑dimensional shift of attention, EDS). In the EDS 
stage the correct and incorrect stimuli changed again, 
but the originally relevant dimension became irrelevant 
and the formerly irrelevant dimension became relevant. 
In the last, EDS‑Rev stage, stimuli did not change, but the 
previously incorrect stimulus became a correct‑reinforced 
one; the irrelevant dimension was still not predictive of 
the reinforcer. 
Animals performed each of the ASST stages in a single 
test session (single day; one stage per day). The two‑session 
(two consecutive days) procedure was introduced when 
needed in the difficult stages of the test (Rev), because 
in this case mice appeared satiated before the stage was 
completed in 1 day. Behavior was monitored by a camera 
and stored to be analyzed off‑line if needed. 
Behavioral analysis of the results of mutant animals 
(DAT+/− and WT mice) was accomplished for the results 
of the group which went through all ASST stages (DAT+/−, 
n=8; WT, n=8). Five mice of each genotype were used for 
the analyses of test‑induced EGRs expression (EDS‑Rev; WT, 
n=5; DAT+/−, n=5). 
Immunohistochemistry 
Task‑induced expressions of the egr‑1 and egr‑2 were 
analyzed in mutant mice (DAT+/− and WT littermate 
mice). Separate groups of animals were trained to analyze 
the expression of the egr‑1 and egr‑2 after each of the 
ASST stages. Animals were sacrificed one hour after the 
end of the particular ASST training session (separate 
group of mice for each ASST stage; 5 mice in each WT and 
DAT+/− subgroup). Tissues of both genotypes, that were 
concurrently subjected to the same ASST stage, were 
processed in parallel, and then subjected separately to 
egr‑1 and egr‑2 immunolabelings. Additionally, egr‑1 
and egr‑2 immunohistochemistry has been done in 
control, not‑trained, naïve DAT heterozygous (n=6) and 
WT (n=6) animals.
Mice were deeply anesthetized with an overdose of 
Nembutal and perfused transcardially with ice‑cold 0.9% 
NaCl followed by 4% paraformaldehyde in 0.1M phosphate 
buffer, PB, pH 7.4. After perfusion, the brains were removed 
and postfixed in the same fixative for 3 h and then replaced 
with 10% sucrose (10% sucrose in phosphate buffered 
saline, PBS, pH 7.4) for 1 day, followed by 20% sucrose for 
1 day and finally with 30% sucrose for one day. Sections 
were stored in PBS containing sodium azide in 4°C. After 
several washes in PBS, endogenous peroxidase activity was 
blocked by incubation in 0.3% H2O2 in PBS. Then, all sections 
were blocked in PBS containing 2% bovine serum albumin 
2% normal serum blocking solution from the same species 
as the secondary antibody, and 0.1% Triton X‑100 at room 
temperature to avoid non‑specific staining. The sections 
were incubated overnight (egr‑1) or over 3 nights (egr‑2) at 
4°C with a primary antibody (rabbit polyclonal anti‑egr‑1 
antibody, Santa Cruz Biotechnology, Inc; Santa Cruz, CA; 
sc‑189; 1:1000; rabbit polyclonal anti‑egr‑2 antibody, 
Covance; Berkeley, CA; PRB‑236P; 1:1000). These antibodies 
were used previously and evaluated for specificity (DeSteno 
and Schamuss 2008). Then, sections were incubated at 
room temperature with a biotinylated secondary antibody 
(anti‑rabbit IgG, 1:100, Vector Laboratories, Burlingame, 
CA), followed by an incubation in avidin‑biotin‑peroxidase 
complex (Vectastain Elite Kit; Vector Laboratories). The 
reaction was developed by using DAB/urea–H2O2 tablets 
(SigmaFAST, D4293, Sigma) with the addition of nickel 
ammonium sulfate hexahydrate (0.02%), resulting in 
black nuclear staining. All sections were rinsed in PBS and 
Table II. Example of a sequence of discriminations in the ASST
discriminations dimension combinations of exemplars
relevant irrelevant reinforced non‑reinforced
simple discrimination (SD) odor (o) medium (m) o1 o2
compound discrimination (CD) odor medium o1 m1, m2 o2 m1, m2
reversal (Rev) odor medium o2 m1, m2 o1 m1, m2
intra‑dimensional shift (IDS) odor medium o3 m3, m4 o4 m3, m4
extra‑dimensional shift (EDS) medium odor m5 o5, o6 m6 o5, o6
extra‑dimensional shift – reversal (EDS‑Rev) medium odor m6 o5, o6 m5 o5, o6
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mounted onto gelatin‑coated slides, dehydrated, cleared in 
xylene and embedded in DePeX. 
Control experiments were conducted in which brain 
sections were subjected to the immunocytochemistry 
procedure described above, except that the primary or 
secondary antibodies were omitted. 
Microscope pictures of the immunolabeled sections, 
obtained using an Eclipse E600 microscope (Nikon), were 
captured with a computer‑assisted camera using Image‑Pro 
Plus Version 5.0 software (Media Cybernetics, Bethesda, 
MD, USA). Representative examples of egr‑1 and egr‑2 
immunolabeled sections are shown in Figs 3C, 3D and 4B.
Behavioral results revealed profound difficulties 
of DAT+/− mice in the Rev stage of the task 
(Cybulska‑Klosowicz et al. submitted), therefore we 
decided to compare neuronal activation in WT and DAT 
mutant mice in two structures which are well known to 
be involved in the reversal learning – OFC and DMS. The 
expression of egr‑2 and egr‑1 immunoreactivity was 
measured in the ventrolateral part of the OFC (vlOFC) and 
in DMS, determined using The Mouse Brain in stereotaxic 
coordinates (Franklin and Paxinos 1997). Immunolabelling 
was analyzed in sections that were collected from +2.7 to 
+2.1 relative (rostral) to bregma for OFC and +1.1 to +0.5 
relative (caudal) to bregma for DMS. Three to five sections 
from each one animal were analyzed. The vlOFC and DMS 
were determined and outlined in every analyzed section 
in both hemispheres. Image‑J v1.45s software was used 
for automated analysis of the number of egr‑1 and egr‑2 
positive nuclei. A person blinded to the experimental 
conditions performed the analysis. 
In all cases the density of immunoreactive cells is 
presented. The counts for each region were averaged for 
each animal, and the obtained values were used to produce 
a group mean. 
Statistical analyses
Kolmogorov‑Smirnov normality tests were applied 
to all data before statistical comparisons. T‑tests were 
applied to compare the total number of errors (both, 
commission and omission) between compared groups 
of mice (WT vs. DAT+/− mice and GBR 12909‑treated vs. 
control mice). The non‑parametric statistics were applied 
for all the remaining behavioral ASST data (trials to 
criterion), because they did not pass the normality test. 
Comparisons were made using Kruskal‑Wallis tests and 
differences between GBR 12909‑treated and control mice 
were determined with post hoc comparisons (Mann‑Whiney 
U‑tests, with Bonferroni correction). Two‑way analysis of 
variance (ANOVA) was applied to separately analyze the 
results of egr‑1 and egr‑2 immunohistochemistry. For each 
analysis, the effects of “DAT genotype”, “ASST stage” and 
the interaction of those 2 factors on EGRs expression were 
analyzed; post hoc comparisons were conducted using the 
Bonferroni statistics. GraphPad Prism 5 software was used 
for all statistical analyses.
RESULTS
GBR 12909‑treated mice
Response accuracies (number of trials to criterion) of 
GBR 12909 (n=7) and control (n=8) mice on the ASST are 
shown on Fig. 1A. All animals, both GBR 12909‑treated 
and control, were able to complete all of the ASST stages. 
The data did not pass the Kolmogorov‑Smirnov normality 
test, therefore the non‑parametric statistics were 
applied. Kruskal‑Wallis test yielded significant effects 
of drug‑treatment on a ASST test stage performance 
level (Kruskal‑Wallis statistic: 40.57, p<0.0001). GBR 
12909‑treated mice needed significantly more trials to 
reach the criterion in Rev (p=0.025), and extra‑dimensional 
shift – reversal (EDS‑Rev) (p=0.032) stages of the ASST 
(Mann‑Whitney U‑tests with Bonferroni correction). No 
differences in performance between the two groups of 
animals were observed in all the remaining stages (SD, CD, 
IDS, EDS) of the ASST (Fig. 1A). 
To further analyze differences between GBR 
12909‑tretaed and control groups of mice in the reversal 
learning, the number of both commission and omission 
errors in both Rev and EDS‑Rev stages was analyzed. 
GBR 12909‑treated mice committed significantly more 
commission errors than control mice in the Rev (p=0.014) 
and EDS‑Rev (p=0.018) stages of the task (Mann‑Whitney 
U‑tests with Bonferroni correction) (Fig. 1D). No differences 
between both groups of mice in the Rev (control mice – 
1.38+/−0.92; GBR 12909‑treated mice – 1.14+/−1.46) and 
EDS‑Rev (control mice – 0.13+/−0.35; GBR 12909‑treated 
mice – 0) stages were found for omission errors (p>0.05; 
Mann‑Whitney U‑tests with Bonferroni correction). The 
total number of commission errors was significantly higher 
in GBR 12909‑treated mice in comparison with control mice 
(t=3.605; df=13; p=0.003; t‑test) (Fig. 1B). The total number 
of omission errors was low in both group of mice (control 
mice – 1.85+/−1.36; GBR 12909‑treated mice – 2+/−2.16) and 
there was no significant difference between the two groups 
of animals (t=0.1362; df=13; p=0.89; t‑test) (Fig. 1C).
DAT+/− and littermate WT mice
Attentional set‑shifting task 
All animals, both DAT+/− and WT, were able to complete 
all of the ASST stages. We have previously shown that 
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DAT+/− mice required significantly more trials than WT 
mice to reach the criterion in Rev, IDS and EDS‑Rev stages 
of the task (Cybulska‑Klosowicz et al. submitted). Moreover, 
contrary to WT mice, there were no difference in the 
performance between IDS and EDS phases in DAT+/− mice. 
Analysis of the data revealed that WT mice could form and 
shift attentional‑set successfully, while it was difficult for 
the DAT+/− mice to acquire and form the attentional set 
(Cybulska‑Klosowicz et al. submitted).
Further analyses of the data, focused on the reversal 
learning, revealed more specific deficits of DAT+/− mice 
and are presented in the current study.
Fig. 1. ASST performance of GBR 12909‑treated and control mice. (A) The individual stages of the ASST are indicated. (B) Total number of commission 
errors committed to criterion in all stages of the ASST. (C) Total number of omission errors committed to criterion in all stages of the ASST. (D) Number 
of commission errors in the Rev and EDS‑Rev stages. For each stage, data are means ±SD. * p<0.05, Kruskal‑Wallis followed by post hoc (Mann‑Whitney 
U‑tests with Bonferroni correction) for A and D; ** p<0.01, t‑test for B and C.
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In order to more thoroughly understand behavioral 
deficits of DAT heterozygous mice in the Rev, IDS and 
EDS‑Rev stages of the ASST task, the numbers of both 
commission errors and omissions to the criterion 
were analyzed in those three stages of the task. 
Statistically significant differences between WT and 
Fig. 2. ASST performance of DAT heterozygotes (DAT+/−) and wild type (WT) mice. (A) The total number of commission errors. (B) The total number of 
omission errors, ** p < 0.01, t‑test. (C) The number of commission errors to criterion and D. the number of omission errors to the criterion in Rev, IS 
and EDS‑Rev stages of the ASST. Individual test stages of the ASST are indicated. For each stage, data are means ±SD of trials to criterion obtained from 
5‑6 animals per genotype. * p<0.05 Kruskal‑Wallis followed by post hoc (Mann‑Whitney U‑tests with Bonferroni correction).
9_1013_Cybulska_v4.indd   182 23/06/17   19:13
The dopamine transporter and reversal learning 183Acta Neurobiol Exp 2017, 77: 176–189
DAT+/− mice were shown for both commission errors 
(Kruskal‑Wallis statistic: 31.30; p<0.0001) and for 
omissions (Kruskal‑Wallis statistic: 52.54; p<0.0001). 
DAT+/− mice committed significantly more commission 
errors than WT mice in the Rev (p=0.042) and IDS 
(p=0.006) stages of the task (Mann‑Whitney U‑tests 
with Bonferroni correction) (Fig. 2C). The number of 
omissions was significantly lower in DAT+/− mice when 
compared with WT mice (p=0.0459; Mann‑Whitney 
U‑tests with Bonferroni correction) (Fig. 2D). The Rev 
stage was the most difficult stage of the ASST task; both 
DAT+/− and WT mice needed significantly more trials 
to reach the criterion and committed significantly 
more commission errors in Rev than in other stages 
(p<0.05 for each of the comparisons; Mann‑Whitney 
U‑tests with Bonferroni correction). The total number 
of commission errors was significantly higher in DAT 
mutant mice in comparison with WT mice (t=3.838; 
df=12; p=0.003; t‑test) (Fig. 2A). There was no difference 
between the two groups of mice in the total number 
of omission errors (t=0.2839; df=12; p=0.78; t‑test) 
(Fig. 2B).
egr‑1 expression
No differences in egr‑1 expression in neither OFC 
(t=0.1990, df=8) nor DMS (t=0.5137, df=8) between naïve 
WT and naïve DAT+/− mice were detected (t‑tests, p>0.05; 
Figs 3A, 3B). 
The data for the egr‑1 expression in both OFC 
and DMS after all stages of the ASST training in WT 
and DAT+/− mice passed the Kolmogorov‑Smirnov 
normality test. Two‑way ANOVA indicated that there 
was a significant interaction between the effects of 
DAT genotype and the ASST stage on the density of 
the egr‑1 immunoreactive cells in the OFC (F(5,48)=3.976, 
p=0.0043). There were significant differences in the 
egr‑1 expression between DAT genotypes (F(1,48)=12.77, 
p=0.0008) and between ASST stages (OFC: F(5,48)=4.915, 
p=0.0010). Within the ASST stage factor post hoc 
comparisons showed that egr‑1 expression was 
significantly lower in DAT+/− mice than in WT mice 
in OFC after completion of the IDS stage (p<0.001) and 
EDS‑Rev stage (p<0.05) (Figs 4A, 4C).
For the DMS there was a significant interaction 
between the effects of DAT genotype and ASST stage 
on egr‑1 expression level (F(5,47)=4.834, p=0.0012). The 
egr‑1 density was significantly affected by the ASST 
stage (F(5,47)=12.62, p<0.0001), and by the DAT genotype 
(F(1,47)=18.45, p<0.0001). Within the ASST stage factor post 
hoc comparisons showed that egr‑1 expression in the DMS 
was significantly lower in mutant mice than in WT mice 
after completion the Rev stage (p<0.05) and IDS stage 
(p<0.001) (Figs 4B, 4D).
egr‑2 expression
As shown in Fig. 3C, no difference between naïve WT 
and naïve DAT heterozygous animals in egr‑2 expression in 
the OFC was detected (t‑test: t=0.2279, df=8, p>0.05).
The data obtained for the egr‑2 expression in OFC 
after ASST in both experimental groups passed the 
Kolmogorov‑Smirnov normality test. Two‑way ANOVA 
indicated that there was a significant interaction 
between the effects of DAT genotype and the ASST stage 
on the density of the egr‑2 immunoreactive cells in the 
OFC (F(5,49)=2.468, p=0.0451) and there were significant 
differences in the egr‑2 expression between ASST stages 
(F(5,49)=3.237, p=0.0133). Within the ASST stage factor 
Fig. 3. Comparison of neuronal activity in OFC and DMS of control, naïve 
DAT mutants (DAT+/−) and wild‑type mice (WT). egr‑1 expression level 
in the OFC (A) and DMS (B) of DAT+/− and WT mice. (C) egr‑2 expression 
level in the OFC of DAT+/− and WT mice. Data represent means ±SD. No 
statistically significant differences were observed between the two groups 
of mice (p>0.05; t‑tests). 
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Fig. 4. (A, B) Comparison of the densities of egr‑1‑labeled cells in the OFC (A) and DMS (B) of DAT mutants (DAT+/−) and wild‑type mice (WT) after completion 
of each particular stage (SD, CD, IDS, Rev, EDS, EDS‑Rev) of the ASST. Data represent means ±SD. Statistical differences revealed by Two‑way ANOVA were 
resolved post hoc (Bonferroni statistics), * p<0.05, ** p<0.01. (C, D) Representative examples of egr‑1‑labeled sections comprising the OFC (C) and DMS (D) 
of WT and DAT+/− mice after IDS testing. Scale bar=100 µm.
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post hoc comparisons showed that egr‑2 expression was 
significantly lower in DAT+/− mice than in WT mice after 
completion the Rev stage in the OFC (p<0.05) (Fig. 5). The 
density of the egr‑2 labeled cells was lower in DAT+/− mice 
in comparison with WT mice after EDS‑Rec stage, too, 
however the difference was not statistically significant.
No clear egr‑2 expression, that could be reliably 
assessed, was observed in the DMS.
DISCUSSION
Behavioral deficits we found in DAT+/− mice imply 
behavioral inflexibility and are accompanied by lower 
task‑induced activation of neurons in regions involved in 
reversal learning, the OFC and DMS. 
Reversal learning is the ability to adjust and inhibit 
a previously learned response and switch responding 
to originally not reinforced stimulus within a particular 
dimension (Birrell and Brown 2000); reversal paradigms 
are among the most widely used tests of behavioral and 
cognitive flexibility (Izquierdo et al. 2017). Reversal has 
been shown to require intact serotonergic innervation 
of the forebrain neocortex (Clarke et al. 2007); however, 
dopaminergic mechanisms in mediating reversal learning 
have also been implicated in several pharmacological 
studies (Cools et al. 2007, Lee et al. 2007, Boulougouris et al. 
2009, Haluk and Floresco 2009, for a review see: Izquierdo et 
al. 2017). Although it has been postulated that the DA effect 
is mediated mainly at the level of the striatum (Dodds et 
al. 2008), there is also evidence for a role of orbitofrontal 
dopamine D1 and D2 receptors in the reversal learning 
(Calaminus and Hauber 2008, Jocham et al. 2009), and of 
OFC and mPFC D1 and D2 receptors in behavioral flexibility 
(Winter et al. 2009). The results of our study reveal deficits 
of DAT mutant mice and in mice withdrawn from the 
treatment with DAT inhibitor in the reversal learning of 
ASST (both Rev and EDS‑Rev). DAT heterozygotes and GBR 
12909‑treated mice were able to learn, but learning was 
significantly slower (more trials to criterion) than in WT 
and control mice and they committed more commission 
errors to the criterion in the Rev stage (and IDS) than WT 
and control mice. Difficulties in the reversal task have 
been previously shown in DAT+/− mice when tested in 
the H‑maze (Del’Guidice et al. 2014) and have also been 
produced by reductions in striatal dopamine transporters 
evoked by methamphetamine administration (Izquierdo et 
al. 2010). Treatment of mice with the potent and selective 
Fig. 5. (A) Comparison of the egr‑2 expression in the OFC of DAT mutants (DAT+/−) and wild‑types (WT) at all stages of the ASST. Data represent means ±SD. 
Statistical differences revealed by Two‑way ANOVA were resolved post hoc (Bonferroni statistics), ** p<0.01, *** p<0.001. (B) Representative examples of 
egr‑2‑labeled sections comprising the OFC of WT and DAT+/− mice after Rev testing. Scale bar=100 µm.
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DAT inhibitor GBR 12909 (van der Zee et al. 1980, Heikkila 
and Manzino 1984, Andersen 1989) would be expected 
initially to reduce DAT activity, but subsequently upon 
drug withdrawal, induce a rebound DAT over‑expression, 
as has been previously postulated (Hewitt et al. 2005, 2009). 
Based on both excessive and deficient DA transmission in 
clinical and experimental studies, an inverted “U‑shaped” 
relationship between DA levels and cognitive performance 
has been postulated (Cools 2006) and our results are in 
agreement with that assumption. It has been shown, that 10, 
20 and 30 days withdrawal from GBR 12909 pre‑treatment 
results in disability in discrimination a familiar over a novel 
object in the novel object discrimination task, indicating 
impaired learning and memory (Hewitt et al. 2009). Our 
study, to the best of our knowledge, is the first showing 
impaired reversal learning and deficits in behavioral 
flexibility after withdrawal from GBR 12909.
Less omission errors together with more commission 
errors during reversal learning in DAT heterozygous mice 
than in WT mice, suggests impulsive action in mutant 
mice. The most effective treatments for impulse control 
disorders, such as ADHD, are agents that target DAT and 
enhance dopamine transmission (Ritz and Kuhar 1989, 
Volkow et al. 1998). Acute GBR 12909 increased impulsive 
choice and action in rats (Evenden and Ryan 1996, van 
Gaalen et al. 2006, Baarendse and Vanderschuren 2012), 
therefore it has been postulated that DAT inhibition 
mediates impulsivity. Indeed, the results of the recent 
study, showing that that impulsive behavior in cued go/
no‑go task is associated with inherent variation in DAT level 
(decreased DAT function) in OFC (Yates et al. 2016), confirm 
that assumption. Our results, showing more commission 
errors in GBR 12909‑treated in comparison with control 
mice but no differences between these groups of mice in 
the number of omission errors, fortify the assumption 
indicating that DAT inhibition, rather than up‑regulation, 
influences impulsive behavior.
A large body of experiments has identified a crucial 
role for both OFC and DMS in mediating flexible behavior 
and it has been shown that reversal learning is sensitive 
to lesions of these two brain regions (Divac et al. 1967, 
Dias et al. 1996, Schoenbaum et al. 2002, Ragozzino 2002a, 
2002b, Ragozzino et al. 2002, McAlonan and Brown 2003, 
Stefani and Moghaddam 2006, Ragozzino 2007, Clarke et al. 
2008, McDonald et al. 2008, Castañe et al. 2010, Baker and 
Ragozzino 2014, Tait et al. 2017). It has been postulated 
that OFC and DMS form a functional frontocorticostriatal 
circuit crucial for mediating behavioral flexibility during 
reversal learning (Castañe et al. 2010). DAT mutant mice 
have persistent hyperdopaminergic tone in the striatum 
(Gainetdinov et al. 1999). This may give rise to striatum 
dysfunction, leading to learning deficits. In heterozygotes 
the neurochemical adaptations in the striatum are all 
intermediate, between that of wild‑type and homozygote 
animals (Jones et al. 1998), and the extracellular dopamine 
levels in the prefrontal cortex are normal (Shen et al. 2004). 
However, since prefrontal cortex has dense connections 
with the dorsomedial striatum (Berendse et al. 1992), subtle 
changes in the corticostriatal dopaminergic circuitry balance 
undoubtedly occur and influence behavioral flexibility 
which arises from that corticostriatal circuit (Pennartz et al. 
2009, Kehagia et al. 2010). Indeed, decreased spine density of 
pyramidal neurons in the mPFC in DAT‑KO mice (Kasahara 
et al. 2015) and the lack of long‑term potentiation (LTP) 
in the prefrontal cortex of these mice (Xu et al. 2009) has 
been reported. This could cause hypofunction of the region 
and contribute to the behavioral abnormalities, including 
cognitive deficits (Giros et al. 1996, Morice et al. 2007). It can 
be assumed that in heterozygous mice these deficiencies 
are not as explicit as in DAT‑KO mice and indeed, normal 
basic behavior, learning and memory in DAT heterozygous 
mice have been reported in previous studies (Zhuang et al. 
2001, Rodriguiz et al. 2004, Morice et al. 2007, Li et al. 2010). 
However, our study revealed that they have deficits in more 
complex tasks requiring executive functions and behavioral 
flexibility. Besides behavioral difficulties, DAT+/− mice had 
also deficits in neuronal activation of regions involved in 
tasks assessing behavioral flexibility – OFC and DMS. In OFC 
our data revealed a lower test‑induced egr‑2 expression in 
the reversal learning stage of the ASST task and also lower 
egr‑1 expression in extra‑dimensional shift‑reversal. In the 
DMS egr‑1 expression was lower in reversal stage in mutant 
mice than in WT mice. The results of control experiments, 
showing no differences in the level of egr‑1 and egr‑2 in 
neither OFC nor DMS of control, naïve DAT+/− and WT mice, 
confirm that the lower level of EGRs in OFC and DMS indeed 
represents deficits in neuronal activation in these regions 
of DAT mutant mice brains during reversal learning and 
intra‑dimensional shift. 
Behavioral pattern observed in DAT mutant mice 
suggests that DAT+/− mice suffer from different cognitive 
deficiencies in comparison with mice with lesions or 
inactivation of specific prefrontal cortex subregions. The 
results also show that the impairment might have more to do 
with perturbations in behavioral flexibility and inhibitory 
control and less to do with deficits in learning and memory 
processes per se (no deficits in SD and CD learning stages of 
the ASST). Moreover, in previous studies it has been shown 
that DAT‑KO mice exhibit impairments in spatial memory 
and reversal learning in the Morris water‑maze (Morice et 
al. 2007) and impairments in response inhibition in eight 
arms radial maze (Gainetdinov et al. 1999). Taken together, 
this suggests that DAT heterozygous mice may suffer from 
cognitive deficits involving not only the OFC and striatum, 
but possibly also other frontal cortex subregions. Indeed, 
in DAT heterozygous mice slower learning (more trials to 
criterion) was also found during IDS stage of the ASST in the 
present study accompanied by the lowered task‑induced 
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neuronal activation in the OFC. It has been shown previously, 
that OFC‑lesioned rats failed to form an attentional set 
and it has been proven that the set‑formation impairment 
in these rats was not caused by the impaired preceding 
reversal, but rather it was an impairment in its own right 
(Chase et al. 2012). During IDS stage we have observed 
lower level of task‑induced egr‑1 expression, but not egr‑2 
expression. It has been previously postulated, that egr‑2 
rather than egr‑1 is a highly sensitive molecular tool to 
identify specific neuronal populations that support distinct 
domains of cognitive control, and a functional link between 
egr‑2 expression levels in the OFC and mPFC and optimal 
ASST performance has been shown (DeSteno and Schmauss 
2008). Reduced egr‑2 expression in the OFC detected only 
after completion of the Rev stage, in which mice exhibited 
deficits, clearly point to the specific deficiency of neuronal 
activation of that region in mice with a decreased DAT level. 
Therefore, behavioral inflexibility and impaired reversal 
learning in these mice may be partly due to the decreased 
task‑induced neuronal activation found in OFC and DMS.
The current results demonstrate that lowered DAT 
function in OFC and DMS is linked to deficiencies in 
behavioral flexibility. Both direct and indirect effects of the 
DAT reduction could contribute to the altered performance 
of DAT+/− mice in the ASST. Although extracellular 
dopamine levels in the prefrontal cortex of DAT‑KO mice are 
normal (Shen et al. 2004), their frontal cortical dopamine 
content is approximately 50% of wildtype levels (Sora et al. 
1998), which may indicate changes in synaptic DA content. 
It has also been shown that serotonin levels are increased 
in DAT heterozygotes and DAT‑KO mice in prefrontal cortex 
(Fox et al. 2013), which might be of special interest in the 
face of evidence implicating serotonin in the OFC in the 
ability of animals to adapt their responding to changes in 
reward contingencies in the environment. Further studies 
are needed to determine whether there are postsynaptic 
differences in dopaminergic function which might 
contribute to deficits in DAT heterozygous mice that are 
reported here, to specify changes in prefrontal areas and 
to explain mechanisms by which this contribute to the 
behavioral/cognitive abnormalities observed in these mice.
CONCLUSIONS
Data presented here reveal impairments in executive 
functions in mice with altered dopamine transporter levels. 
The ASST, complex behavioral paradigm used in training of 
DAT mutant mice and in mouse model of DAT up‑regulation, 
allowed identification of changes in the level of behavioral 
flexibility. The results of this study validate usefulness 
of DAT heterozygotes and ASST for investigation of the 
neurobiological and physiological mechanism underlying 
dysexecutive syndromes related to imbalance in the 
dopaminergic system, such as ADHD and schizophrenia. 
The study provides evidence that altered DAT function, 
specifically in OFC and DMS, underlies deficits in behavioral 
flexibility. 
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